Hydroxychloroquine Procurement and Revenue Forecasts 2030
Hydroxychloroquine Category Overview The global hydroxychloroquine category is expected to grow at a CAGR of 10.1% from 2023 to 2030. It is anticipated to be driven by the increasing prevalence of diseases like rheumatoid arthritis and malaria in low-income nations, increasing penetration of generic drugs, advancement of medical sciences, research & development in the pharmaceutical sector, increased government and consumer healthcare spending on drugs and medications, rising awareness towards health, and growing population. In addition, the category has witnessed a significant surge in its demand since past few years owing to certain studies that have demonstrated its effectiveness against the COVID-19 virus. As a result, many key players in the market have revamped their production capacity to produce and deliver higher amounts of hydroxychloroquine across the globe. Order your copy of the Hydroxychloroquine Procurement Intelligence Report, 2023 - 2030 , published by Grand Vie...